Founded in 2015, XpectVision Technology is a high-tech company committed to disruptive and innovative technology development. XpectVision has been trailblazing in the field of photon-counting X-ray imaging, applying it in areas like medical, industry and laboratory research. Also the company is poised to be the leader of other futuristic imaging technology.

The development team boasts of 50 talented staff members. Prior to joining XpectVision, most of these members received advanced degrees from highly ranked institutions, such as Cornell, CalTech, University of Texas at Austin, UT MD Anderson Cancer Center, Tsinghua University, and Peking University. The R&D team has made over 300 core invention patents, building up a wide intellectual property rights portfolio.  

XpectVision leads in the new-generation photon-counting X-ray counting technology, making the innovative detector-based mammography systems and digital intraoral X-ray sensor. In industry, the technology has been applied in 2D and 3D digital X-ray imaging, and in laboratory research, we have developed synchrotron radiation detector.

XpectVision is very proud to have been invested by the following funds：IDG Capital, China International Capital Corporation Limited, CAS Investment Management Co. Ltd, Northern Light Venture Capital and others.

、